Neuraminidase inhibitors from Reynoutria elliptica

Archives of Pharmacal Research

Volumn 26, Issue 5, 2003, Pages 367-374

  Lee, Chu Hyun ^a   Kim, Sang In ^a   Lee, Kyung Bok ^b   Yoo, Yung Choon ^b   Ryu, Si Young ^c   Song, Kyung Sik ^a  

^a Kyungpook National University   (South Korea)

^b Konyang University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Emodin; Emodin 3 methyl ether; Influenza; Neuraminidase inhibitor; Physcion; Reynoutria elliptica; trans Resveratrol; Hydroxy emodin

Indexed keywords

EID: 0242686235     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02976693     Document Type: Article

References (18)

1. Burmeister, W. P., Ruigrok, R. W., and Cusack, S., The 2.2 resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J., 11, 49-56 (1992).
2. Chen, L., Han, Y., Yang, F., and Zhang, T., High-speed counter-current chromatography separation and purification resvertrol and piceid Polygonum cuspidatum. J. Chromatogr. A., 907, 343-346 (2001).
3. Colman, P. M., Influenza virus neuraminidase: structure, antibiotics and inhibitors. Protein Sci., 3, 1687-1696 (1994).
4. Colman, P. M., Design and antiviral properties of influenza virus neuraminidase inhibitors. Pure Appl. Chem., 67, 1683-1688 (1995).
5. Colman, P. M., A novel approach to antiviral to therapy for influenza. J. Antimicrob. Chemother., 44, 17-22 (1999).
6. 13C NMR spectra of anthraquinone glycoside from Rhamnus frangula. Mag. Res. Chem., 36, 769-772 (1998).
7. Gottschalk, A., The specific enzyme of influenza virus and Vibrio cholerae. Biochem. Biophys. Acta., 23, 645-646 (1957).
8. Klenk, H. O. and Rott, R., The molecular biology of influenza virus pathogenicity. Adv. Virus Res., 34, 247-280 (1988).
9. Ko, S. K., Whang, W. K., and Kim, I. H., Anthraquinone and stilbene derivatives from the cultivated Korean Rhubarb Rhizomes. Arch. Pharm. Res., 18, 282-288 (1995).
10. Lin, C., Eichelberger, M. C., Compans, R. W., and Air, G. M., Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly or budding. J. Virol., 69, 1099-1106 (1995).
11. Likhitwitayawuid, K., Sritularak, B., and De-Eknamkul, W., Tyrosinase inhibitors from Artocarpus gomezianus. Planta Medica, 66, 275-277 (2000).
12. Murakami, H., Kobayashi, J., Musuda, T., Morooka, N., and Ueno, Y., ω-Hydroxyemodin, a major hepatic metabolite of emodin in various animals and its mutagenic activity. Mutation Res., 180, 147-153 (1987).
13. Myers, R. W., Lee, R. T., Lee, Y. C., and Thomas, G. H., The synthesis of 4-methylumberiferyl α-ketoside of N-acetylneuraminic acid and its use in a fluorometric assay for neuraminidase. Anal. Biochem., 101, 166-174 (1980).
14. Palese, P. and Compans, R. W., Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro- Ntrifluoroacetyl neuraminic acid (FANA): mechanism of action. J. General Virol., 33, 159-163 (1976).
15. Palese, P., Tabita, U., Ueda, M., and Compans, R. W., Characterization of temperature sensitive influenza virus mutants. Virology, 61, 397-410 (1974).
16. Varghee, J. N., Mckimm-Breschkin, J. L., Caldwell, J. B., Kortt, A. A., and Colman, P. M., The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Protein, 14, 327-332 (1992).
17. von Itzstein, N., Kok, G. B., and Pegg, M. S., Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature, 363, 418-423 (1993).
18. Willey, D. C. and Skehel, J. J., The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem., 56, 365-394 (1987).